Ketogenic diet has been
proposed for the adjuvant therapy in the treatment of brain tumors. The
rationale behind using ketogenic diet in the cancer treatment is the inability
of tumor mitochondria to oxidize KBs. Recent studies on ketone body metabolism
using 9L and RG2 cell lines and glioma models suggest that brain tumor
mitochondria are capable of oxidizing ketone bodies. The current study was undertaken
to determine relative utilization of betahydroxy-butyrate (BHB) and glucose in patient-derived
glioblastoma cells. Our findings clearly indicate that human brain tumor cells are fully capable of oxidizing ketone bodies even under
normoglycemic conditions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords